vimarsana.com

Page 14 - Nccn Guidelines News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Patient Profile: A 72-Year-Old Man with mCRPC and Multiple Bone Metastases

Radiation oncologist Matthew Manning, MD, shares the patient profile of a 72-year-old man with mCRPC receiving palliative treatment with radium-223.

Matthew manningTreatment approachMetastatic castration resistant prostate cancerYear old manMultiple boneProstate cancerMcrpc treatmentMcrpc radiationMcrpc medical oncologyBone painPalliative radiationSabr cometNccn guidelinesRadium 223

Real-World Use of HER2-Directed Therapies in Colorectal Cancers

Expert perspectives on the real-world use of HER2-directed therapies in patients with HER2-amplified colorectal cancer.

Positive colorectal cancerNovel approachesWorld useDirected therapiesColorectal cancersColorectal cancerMetastatic crcColon cancerRectal cancerHer2 positiveTrastuzumab deruxtecanT dxdNccn guidelinesTreatment guidelinesTreatment selectionTreatment sequencing

Patient Profile: A 78-Year-Old Man with mCRPC

Dr Andrew Armstrong presents a profile of a 78-year-old man with mCRPC with a single PSMA-avid bone metastasis and asks Dr Manning how he would treat the patient in question.

Andrew armstrongTreatment approachMetastatic castration resistant prostate cancerYear old manProstate cancerMcrpc treatmentMcrpc radiationMcrpc medical oncologyBone painPalliative radiationSabr cometNccn guidelinesRadium 223

Treatment Approaches for Patients with mCRPC and Bone-Only Disease Progression After Radiotherapy

Drs Manning and Armstrong discuss the best treatment approaches for a patient with mCRPC and disease progression in the bone after initial radiotherapy for metastatic disease.

Treatment approachMetastatic castration resistant prostate cancerBone only disease progression afterProstate cancerMcrpc treatmentMcrpc radiationMcrpc medical oncologyBone painPalliative radiationSabr cometNccn guidelinesRadium 223

Treatment Sequencing Approaches for Myelofibrosis

Expert perspectives on treatment sequencing strategies with JAK inhibitors for myelofibrosis.

Myeloproliferative neoplasmsSequencing approachesTreatment sequencingJak inhibitor therapyNccn guidelinesCombination treatment strategiesNovel therapiesClinical trialsAdjunctive therapy

vimarsana © 2020. All Rights Reserved.